COVID-19: An Accelerator of Existing Trends

article image

What are the strategic implications for medtech companies as they contemplate the “post-COVID-19” world? L.E.K. Consulting looks at the near-term and longer-term impacts. By Jonas Funk, Monish Rajpal, Ilya Trakhtenberg, and Sheila Shah, L.E.K. Consulting.

There is no doubt that COVID-19 has had a severe impact on the US healthcare ecosystem (as well as the rest of the economy) as providers have focused on managing and caring for COVID-19 patients. The near-term impact, particularly the reduction in elective procedures and physician office visits, has been the focus of major stakeholders in the healthcare ecosystem. Now, as the resumption of physician visits and elective procedures gains traction, the longer-term impacts of COVID-19 are becoming a growing area of focus, given the major changes that will persist even after COVID-19 completes its destructive path. 

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: